- Investor Presentation
- Licence Agreement in Canada for AccruferÂ®
- Second Price Monitoring Extn
- Price Monitoring Extension
- Patient Access Expands for AccruferÂ®
- Block Listing 6 Monthly Return
- Jose A. Menoyo Appointed as Chief Medical Officer
- Investor presentation
- PDMR Transaction Notification
- Half-year Report
Shield Therapeutics PLC (1JS:DEU) closed at 0.428, 37.18% above the 52 week low of 0.312 set on Dec 15, 2021.
0.312Dec 15 20210.715Jun 01 2021
Markit short selling activity
|Market cap||80.94m GBP|
|EPS (TTM)||-0.0817 |
Data delayed at least 15 minutes, as of Jan 21 2022 14:26 GMT.